Upregulation of EGFR leads to activation of EGFR signaling and promotes tumor progression through EGFR downstream pathways, including PI3K/Akt/mTOR and RAS/MEK/ERK pathways.39, 40. Here, MAP2K7 is linked to neoplasm.